Published in Breast Cancer Res Treat on August 12, 2010
Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer (2013) 3.75
The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy. Br J Cancer (2011) 0.84
Individual risk profiling for breast cancer recurrence: towards tailored follow-up schemes. Br J Cancer (2013) 0.83
Comparison of recurrence and survival rates after breast-conserving therapy and mastectomy in young women with breast cancer. Curr Oncol (2013) 0.80
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy. Breast Cancer Res (2014) 0.79
Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis. Oncotarget (2015) 0.77
The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer. Cureus (2016) 0.75
Optimal approach in early breast cancer: Radiation therapy. EJC Suppl (2013) 0.75
Should breast conservation be offered to young women with breast cancer? Breast Cancer Res Treat (2010) 0.75
Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med (2009) 5.82
Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med (2009) 5.36
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). Lancet Oncol (2007) 3.32
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol (2006) 2.48
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol (2012) 2.16
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis. Eur J Cancer (2012) 2.07
Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma. Cancer (2003) 1.74
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. N Engl J Med (2015) 1.70
Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. J Pathol (2004) 1.67
International study on low-grade primary central nervous system lymphoma. Ann Neurol (2006) 1.59
Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat (2010) 1.53
Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat (2010) 1.52
Microsurgical techniques for the treatment of breast cancer-related lymphedema: a systematic review. J Reconstr Microsurg (2012) 1.46
Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study. Eur J Cancer (2010) 1.42
Signalling pathways in vasculogenic mimicry. Biochim Biophys Acta (2010) 1.38
Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin Chem (2004) 1.36
P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol (2009) 1.29
Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting. Radiother Oncol (2011) 1.27
Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature. Breast Cancer Res Treat (2009) 1.25
Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer. J Clin Oncol (2006) 1.24
Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer (2012) 1.23
Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature. Radiat Oncol (2010) 1.23
Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening. Cancer (2004) 1.17
Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Breast Cancer Res (2012) 1.16
Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics. Int J Technol Assess Health Care (2009) 1.14
Clinical management of women with metastatic breast cancer: a descriptive study according to age group. BMC Cancer (2006) 1.14
Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis. Breast Cancer Res Treat (2010) 1.13
The role of surgery in metastatic breast cancer. Eur J Cancer (2011) 1.13
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. Eur J Cancer (2005) 1.10
Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol (2002) 1.10
Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment? Ann Surg (2016) 1.08
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer. Oncogene (2003) 1.08
Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst (2008) 1.07
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome. Breast Cancer Res Treat (2013) 1.04
Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res (2007) 1.04
Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ (2004) 1.01
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer (2009) 1.01
Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat (2013) 0.99
Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. Eur J Cancer (2008) 0.99
Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002. Breast (2007) 0.99
Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%. J Gastrointest Surg (2007) 0.98
Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann Surg Oncol (2010) 0.96
Anxiety after an abnormal screening mammogram is a serious problem. Breast (2011) 0.96
Interobserver variability of laryngeal mucosal premalignant lesions: a histopathological evaluation. Mod Pathol (2011) 0.96
Chronic abdominal wall pain misdiagnosed as functional abdominal pain. J Am Board Fam Med (2013) 0.96
Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg (2012) 0.96
Subareolar breast abscesses: characteristics and results of surgical treatment. Breast J (2005) 0.95
ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma. Int J Cancer (2006) 0.95
COX-2 polymorphisms and the risk for head and neck cancer in white patients. Head Neck (2009) 0.95
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival. Ann Surg (2014) 0.95
Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Int J Cancer (2002) 0.93
A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial). BMC Surg (2010) 0.92
Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology (2010) 0.91
The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: a rare cancer network retrospective study. Radiother Oncol (2005) 0.91
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Gynecol Oncol (2007) 0.91
Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol (2006) 0.91
Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care. Cancer (2007) 0.91
Surgical management of inguinal neuralgia after a low transverse Pfannenstiel incision. Ann Surg (2008) 0.91
Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy. J Clin Oncol (2008) 0.90
Re-attendance at biennial screening mammography following a repeated false positive recall. Breast Cancer Res Treat (2014) 0.90
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia. J Clin Oncol (2013) 0.89
Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer. Cancer Res (2004) 0.89
The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years. Cancer (2007) 0.89
Introduction of additional double reading of mammograms by radiographers: effects on a biennial screening programme outcome. Eur J Cancer (2008) 0.89
Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study). BMC Surg (2009) 0.88
Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005. Eur Radiol (2008) 0.88
Considering early detection of relapsed ovarian cancer: a review of the literature. Int J Gynecol Cancer (2011) 0.88
Taxane resistance in breast cancer: a closed HER2 circuit? Biochim Biophys Acta (2012) 0.87
A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer. Breast Cancer Res Treat (2007) 0.86
Breast cancers found by screening: earlier detection, lower malignant potential or both? Breast Cancer Res Treat (2002) 0.86
Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal cancer patients. Ann Surg Oncol (2012) 0.86
Reduction of postoperative ileus by early enteral nutrition in patients undergoing major rectal surgery: prospective, randomized, controlled trial. Ann Surg (2014) 0.86
SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. BMC Surg (2012) 0.86
Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer? Clin Chem (2006) 0.86
Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study. Breast Cancer Res Treat (2011) 0.86
A brachialis muscle rupture diagnosed by ultrasound; case report. Int J Emerg Med (2011) 0.85
Prostatic duct adenocarcinoma: clinical characteristics, treatment options, and outcomes - a Rare Cancer Network study. Onkologie (2010) 0.85
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884). Int J Radiat Oncol Biol Phys (2005) 0.84
Bridging trial and decision: a checklist to frame health technology assessments for resource allocation decisions. Value Health (2011) 0.84
Microsomal epoxide hydrolase genotypes and the risk for head and neck cancer. Head Neck (2008) 0.83
High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast Cancer Res Treat (2006) 0.83
Transferability of model-based economic evaluations: the case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands. Value Health (2010) 0.83
Mammographic changes resulting from benign breast surgery impair breast cancer detection at screening mammography. Eur J Cancer (2012) 0.83
Improving the quality and efficiency of follow-up after curative treatment for breast cancer--rationale and study design of the MaCare trial. BMC Cancer (2007) 0.83
Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study. Ann Surg Oncol (2012) 0.83